Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**TOX4P1 (TOX high mobility group box family member 4 pseudogene 1)** is classified as a pseudogene, meaning it is a DNA sequence similar to a protein-coding gene (TOX4) but is nonfunctional and generally does not code for a protein[3][8]. It is not considered a therapeutic target, receptor, enzyme, transporter, or functional transcription factor. Pseudogenes may sometimes be transcribed into RNA and, in rare cases, can influence gene regulation at the RNA level, including microRNA (miRNA) decoy activity or generation of small interfering RNAs (siRNAs) impacting their cognate protein-coding genes[2][4]. However, there is no direct evidence that TOX4P1 specifically has any such regulatory role, nor any links to disease or drug interaction in current knowledge. Its main biological and clinical relevance is as a non-coding, likely nonfunctional, genomic element. **Note:** If the intent was to refer to the functional protein-coding gene, "TOX4 (TOX high mobility group box family member 4)," this is distinct from TOX4P1—the former is a transcription factor involved in chromatin structure and gene regulation[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TOX high mobility group box family member 4 pseudogene 1 (TOX4P1).